Sign In
Buy CDXS
$2.72
+0.0300 (+1.12%)
At Close: Jun 03, 2026
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
04:05pm, Tuesday, 19'th Nov 2024
REDWOOD CITY, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
04:05pm, Thursday, 14'th Nov 2024
—Becomes first company to showcase four routes of synthesis for approved siRNA therapeutic asset— —Joint poster with Bachem demonstrates superiority of Company's double-stranded RNA ligases comp
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors
04:05pm, Tuesday, 12'th Nov 2024
REDWOOD CITY, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced t
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics
04:05pm, Monday, 11'th Nov 2024
—Spotlight Presentation to showcase four routes of synthesis of an approved siRNA therapeutic asset— —Joint poster presentation with Bachem to compare Codexis double-stranded RNA ligase to wild-
Codexis Announces New Employment Inducement Grants
04:05pm, Friday, 08'th Nov 2024
REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced t
Codexis to Participate in Upcoming Healthcare Conferences
04:05pm, Monday, 04'th Nov 2024
REDWOOD CITY, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced t
Codexis, Inc. (CDXS) Q3 2024 Earnings Call Transcript
10:48pm, Thursday, 31'st Oct 2024
Codexis, Inc. (CDXS) Q3 2024 Earnings Call Transcript
Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates
06:31pm, Thursday, 31'st Oct 2024
Codexis (CDXS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to loss of $0.26 per share a year ago.
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
04:05pm, Thursday, 24'th Oct 2024
Oral Presentations to Highlight Results of Customer Collaborations using the ECO Synthesis™ Platform Oral Presentations to Highlight Results of Customer Collaborations using the ECO Synthesis™ Pla
Codexis Announces New Employment Inducement Grants
07:05am, Monday, 14'th Oct 2024
REDWOOD CITY, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced t
Codexis to Report Third Quarter 2024 Financial Results on October 31
04:05pm, Thursday, 10'th Oct 2024
REDWOOD CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced t
Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company
04:05pm, Wednesday, 02'nd Oct 2024
Company raises $31 million through ATM, bringing cash runway into 2027 New additions to leadership in technical operations, finance and intellectual property prepare Codexis for the next phase of grow
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences
07:05am, Tuesday, 01'st Oct 2024
Non-exclusive license includes HiFi DNA Polymerase, HiTemp Reverse Transcriptase, HiRev Isothermal Polymerase and other enzymes for genomics and diagnostic applications Non-exclusive license includes
Codexis Announces New Employment Inducement Grants
04:05pm, Friday, 06'th Sep 2024
REDWOOD CITY, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to three new employees as app
Codexis to Participate in Upcoming Healthcare Conferences
04:05pm, Tuesday, 03'rd Sep 2024
REDWOOD CITY, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that management will participate in two upcoming investor c
